| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/25/2004 | WO2003046578A3 Method for the assessment and prognosis of sarcoidosis |
| 03/25/2004 | WO2003044210A3 Process for preparing insulin compounds |
| 03/25/2004 | WO2003042243A3 Immunogenic alk (anaplastic lymphoma kinase) peptides |
| 03/25/2004 | WO2003040296A3 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 03/25/2004 | WO2003037361A3 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis |
| 03/25/2004 | WO2003031472A3 Insulin mimetic amino acid sequences |
| 03/25/2004 | WO2003027081A3 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 03/25/2004 | WO2003020749A3 Ncam binding compounds |
| 03/25/2004 | WO2003016351A3 N - cam related compounds modulating cell groth |
| 03/25/2004 | WO2003015812A3 Beta-amyloid-analogue-t-cell epitop vaccine |
| 03/25/2004 | WO2003014731B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 03/25/2004 | WO2003012122A8 Crystallized structure of type iv collagen nc1 domain hexamer |
| 03/25/2004 | WO2003010186A3 Method for making acylated polypeptides |
| 03/25/2004 | WO2003010185A3 Method for making acylated polypeptides |
| 03/25/2004 | WO2003006501A3 G-csf conjugates |
| 03/25/2004 | WO2003004618A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/25/2004 | WO2003004519A9 Icosahedral superstructures of vp2 of infectious bursitis virus (ibdv) and the applications thereof |
| 03/25/2004 | WO2002102993A3 Human secreted proteins |
| 03/25/2004 | WO2002102829A3 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 03/25/2004 | WO2002102399A3 Mucosal repair by tff2 peptides |
| 03/25/2004 | WO2002097441A3 Mammalian diabetes-mediating proteins |
| 03/25/2004 | WO2002096942A3 Recombinant dna encoding the major allergen of plantago lanceolata pollen pla l 1, and applications thereof |
| 03/25/2004 | WO2002095065A3 G-protein coupled receptor arrays |
| 03/25/2004 | WO2002094855A3 Peptide synthesis method |
| 03/25/2004 | WO2002085093A3 Replikin peptides and uses thereof |
| 03/25/2004 | WO2002083859A8 Surface proteins of streptococcus pyogenes |
| 03/25/2004 | WO2002081629A3 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 03/25/2004 | WO2002079492A8 Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators |
| 03/25/2004 | WO2002074048A3 P-glycoproteins and uses thereof |
| 03/25/2004 | WO2002063006A3 Receptors and membrane-associated proteins |
| 03/25/2004 | WO2002059321A3 Hepatitis c virus replicons and replicon enhanced cells |
| 03/25/2004 | WO2002055557A3 Human proteins and nucleic acids encoding same |
| 03/25/2004 | WO2002051433A3 Use of artemin, a member of the gdnf ligand family for preparing a neuroprotective medicament |
| 03/25/2004 | WO2002044342A3 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 03/25/2004 | WO2001092470A3 Dna expression vectors and methods of use |
| 03/25/2004 | US20040060084 Regulatory nucleotide sequences for controlling anther specific expression of heterologus genes and proteins |
| 03/25/2004 | US20040060081 Plant genes that confer resistance to strains of magnaporthe grisea having avri co39 cultivar specificity gene |
| 03/25/2004 | US20040060079 Method of controlling character of monocotyledon by modification and/or overexpression of cytochrome P450 monooxygenase gene involved in brassinosteroid biosynthesis and monocotyledon modified by the gene |
| 03/25/2004 | US20040059098 Egf motif protein, egfl6 materials and methods |
| 03/25/2004 | US20040059095 Comprises cytokine polypeptides for diagnosis and treatment of cancer, atherosclerosis, arthritis, ischemia and cardiovascular diseases |
| 03/25/2004 | US20040059094 Hapten-carrier conjugates and uses thereof |
| 03/25/2004 | US20040059093 Methods to construct multimeric DNA and polymeric protein sequences as direct fusions or with linkers |
| 03/25/2004 | US20040059092 G-protein coupled receptors |
| 03/25/2004 | US20040059091 Protein complexes and process for producing the same |
| 03/25/2004 | US20040059090 Novel compounds |
| 03/25/2004 | US20040059089 Comprises receptor protein for controlling gene expression in transgenic cells; for diagnosis, prevention and treatment of heart, tumor and urogenital disorders |
| 03/25/2004 | US20040059087 Peptide nucleic acids |
| 03/25/2004 | US20040058981 Administering free radical generators such as artemisinim, arteflene |
| 03/25/2004 | US20040058887 Releasing drug, cosmetics to cells; flexible kinetics release patterns |
| 03/25/2004 | US20040058884 Detecting diseases by Selex method; anticancer agents |
| 03/25/2004 | US20040058881 Ii-key/antigenic epitope hybrid peptide vaccines |
| 03/25/2004 | US20040058874 Synthetic peptide and uses for same |
| 03/25/2004 | US20040058872 Polypeptides, nucleic acids; gene codes; antibiotic, immunosuppressants |
| 03/25/2004 | US20040058871 Purification a supernatant; electrophoresis; antiproliferative agents; antiinflammatory agent |
| 03/25/2004 | US20040058870 Reduce blood glucose concentration; antidiabetic agent; respiratory system disorders |
| 03/25/2004 | US20040058869 Methods and reagents for modulating cholesterol levels |
| 03/25/2004 | US20040058866 Method for preparing tryptophan rich peptides |
| 03/25/2004 | US20040058865 Homing peptide multimers, their preparation and uses |
| 03/25/2004 | US20040058863 Genetic engineered polypeptide; influenza vaccine, gramnegative bacteria; induce immunology response |
| 03/25/2004 | US20040058862 Novel polypeptides and nucleic acids encoding the same |
| 03/25/2004 | US20040058861 Reaction product of aids protein epitope linked to lipid |
| 03/25/2004 | US20040058860 Novel bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins |
| 03/25/2004 | US20040058859 Multiple antigen glycopeptide carbohydrate vaccine comprising the same and use thereof |
| 03/25/2004 | US20040058849 Fibroblast growth factor receptors and methods for their use |
| 03/25/2004 | US20040058443 Manipulation of non-terminally differentiated cells using the Notch pathway |
| 03/25/2004 | US20040058439 High titer recombinant AAV production |
| 03/25/2004 | US20040058429 Recombinant saccharomyces cerevisiae expressing chimeric glucose transporters |
| 03/25/2004 | US20040058424 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/25/2004 | US20040058416 Human trk receptors and neurotrophic factor inhibitors |
| 03/25/2004 | US20040058414 Preparing antibody capable of binding and inhibiting activity of interleukin-2 and receptor, herpes viral epitopes and interferon receptors; diagnosis and treatment of viral and autoimmune diseases |
| 03/25/2004 | US20040058411 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/25/2004 | US20040058404 Method for examining caries risk |
| 03/25/2004 | US20040058402 Method for purifying the helicobacter adhesin-like protein a (alpa) |
| 03/25/2004 | US20040058399 Evaluating effectiveness of isoniazid preventive therapy in treating tuberculosis |
| 03/25/2004 | US20040058379 Tumor suppressor gene, p47Ing3 |
| 03/25/2004 | US20040058377 Novel G-protein coupled receptors and uses therefor |
| 03/25/2004 | US20040058371 Novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 03/25/2004 | US20040058369 Comprises nucleotide sequences coding heliothis ecdysone receptor for controlling gene transcrption in transgenic animal models |
| 03/25/2004 | US20040058367 Comprises interleukin 1b converting enzyme inhibitor for diagnosis, prevention and treatment of viral, nervous system, ischemic and graft-versus-host diseases |
| 03/25/2004 | US20040058366 Comprises DNA coding brain-muscle-arnt-like protein 2 (BMAL2) for diagnosis and treatment of circadian rythm disorders |
| 03/25/2004 | US20040058365 Molecules for disease detection and treatment |
| 03/25/2004 | US20040058361 Antibacterial treatments |
| 03/25/2004 | US20040058358 Lipid metabolism transcription factor |
| 03/25/2004 | US20040058355 Comprises nucleotide sequences coding membrane proteins for diagnosis and treatment of brain, breast disorders, colon, kidney, inflammatory, brain and urogenital disorders |
| 03/25/2004 | US20040058353 Comprises nucleotide sequences coding transport proteins for diagnosis and treatment of pain, psychotic, eating and nervous system disorders |
| 03/25/2004 | US20040058350 Regulation of human secretin receptor-like gpcr |
| 03/25/2004 | US20040058347 Novel proteins and nucleic acids encoding same |
| 03/25/2004 | US20040058338 Novel proteins and nucleic acids encoding same |
| 03/25/2004 | US20040058337 Process for determining the tumorcidal potential of a sample the use of a nucleic acid which is downregulated in human tumor cells |
| 03/25/2004 | US20040058326 Identification and use of molecules implicated in pain |
| 03/25/2004 | US20040058324 Gene sp17 inhibiting lesion formation in plant and utilization thereof |
| 03/25/2004 | US20040058323 Proteins with repetitive bacterial-Ig-like (big) domains present in leptospira species |
| 03/25/2004 | US20040058321 Comprises nucleotide sequences coding transforming growth factor binding proteins for diagnosis and treatment of osteoporosis and osteopenia |
| 03/25/2004 | US20040058319 Comprises nucleotide sequences coding urogenital polypeptide for diagnosis and treatment cancer |
| 03/25/2004 | US20040058318 Transcripton factor comprising tyrosine kinase and interferon binding domains for diagnosis and treatment of autoimmune and immune response disorders; imunosuppressants |
| 03/25/2004 | US20040058316 Use of recombinant antigens to determine the immune status of an animal |
| 03/25/2004 | US20040057968 T cell binding ligand peptides, peptide constructs containing same and use thereof for treatment of immunological disorders |
| 03/25/2004 | US20040057967 Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding |
| 03/25/2004 | US20040057966 RecA mutant mycobacteria, particularly mutants of mycobacterial species which are members of the Mycobacterium tuberculosis complex, such as M.bovis BCG and M.tuberculosis; immunotherapteutic agents, vaccines, for tuberculosis |
| 03/25/2004 | US20040057963 Therapeutic TB vaccine |